ÂÜÀòÂÒÂ×

Harry Fitzpatrick is currently working as an Investment Executive in the Health & Life Sciences Investment Team at Synova since November 2021. Prior to this, Harry worked as an Origination Analyst in the Health & Life Sciences division at Goldman Sachs. Before that, Harry was a Trader in Equity derivatives at Goldman Sachs. Harry started their career at Goldman Sachs as a Securities Division Spring Intern in 2018 and later worked as a Securities Division Summer Analyst in 2019. Harry holds a MChem degree in Chemistry from the University of Oxford, where they attended from 2016 to 2020.